Mechanistic insights into the stabilization of srcSH3 by PEGylation

Langmuir

Volumn 28, Issue 46, 2012, Pages 16133-16140

  Meng, Wei ^a   Guo, Xinlu ^a   Qin, Meng ^a   Pan, Hai ^a   Cao, Yi ^a   Wang, Wei ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COOPERATIVITY; CORRESPONDING STATE; DENATURANT CONCENTRATION; EXCLUDED VOLUME EFFECTS; EXPERIMENTAL OBSERVATION; FREE ENERGY CHANGE; KINETIC STABILITY; PEGYLATION; PHYSICAL MODEL; PROTEIN PEGYLATION; PROTEIN STABILIZATION; PROTEIN SURFACE; SOLVENT-ACCESSIBLE SURFACE AREA; STABILIZATION EFFECTS; UNDERLYING MECHANISM; WEAK CORRELATION;

FREE ENERGY; MOLECULAR WEIGHT; STABILIZATION; THERMODYNAMIC STABILITY;

PROTEINS;

MACROGOL DERIVATIVE; PROTEIN TYROSINE KINASE;

ANIMAL; ARTICLE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; CHICKEN; CIRCULAR DICHROISM; GENETICS; KINETICS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; SRC HOMOLOGY DOMAIN; THERMODYNAMICS;

ANIMALS; CHICKENS; CIRCULAR DICHROISM; KINETICS; MODELS, CHEMICAL; MODELS, MOLECULAR; POLYETHYLENE GLYCOLS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STABILITY; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES; THERMODYNAMICS;

EID: 84869457102     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la303466w     Document Type: Article

References (59)

1. Leader, B.; Baca, Q. J.; Golan, D. E. Protein therapeutics: a summary and pharmacological classification Nat. Rev. Drug Discovery 2008, 7, 21-39
2. Caravella, J.; Lugovskoy, A. Design of next-generation protein therapeutics Curr. Opin. Chem. Biol. 2010, 14, 520-8
3. Fagain, C. O. Understanding and increasing protein stability Biochim. Biophys. Acta 1995, 1252, 1-14
4. Frokjaer, S.; Otzen, D. E. Protein drug stability: a formulation challenge Nat. Rev. Drug Discovery 2005, 4, 298-306
5. Tang, L.; Persky, A. M.; Hochhaus, G.; Meibohm, B. Pharmacokinetic aspects of biotechnology products J. Pharm. Sci. 2004, 93, 2184-204
6. Fernandez, L. A.; Muyldermans, S. Recent developments in engineering and delivery of protein and antibody therapeutics Curr. Opin. Biotechnol. 2011, 22, 839-42
7. Kontermann, R. E. Strategies for extended serum half-life of protein therapeutics Curr. Opin. Biotechnol. 2011, 22, 868-76
8. Harris, J. M.; Chess, R. B. Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discovery 2003, 2, 214-21
9. Veronese, F. M.; Pasut, G. PEGylation, successful approach to drug delivery Drug Discovery Today 2005, 10, 1451-8
10. Veronese, F. M.; Mero, A. The impact of PEGylation on biological therapies BioDrugs 2008, 22, 315-29
11. Fishburn, C. S. The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics J. Pharm. Sci. 2008, 97, 4167-83
12. Melmed, G. Y.; Targan, S. R.; Yasothan, U.; Hanicq, D.; Kirkpatrick, P. Certolizumab pegol Nat. Rev. Drug Discovery 2008, 7, 641-2
13. Brocchini, S.; Godwin, A.; Balan, S.; Choi, J. W.; Zloh, M.; Shaunak, S. Disulfide bridge based PEGylation of proteins Adv. Drug Delivery Rev. 2008, 60, 3-12
14. Gaberc-Porekar, V.; Zore, I.; Podobnik, B.; Menart, V. Obstacles and pitfalls in the PEGylation of therapeutic proteins Curr. Opin. Drug Discovery Dev. 2008, 11, 242-50
15. Jevsevar, S.; Kunstelj, M.; Porekar, V. G. PEGylation of therapeutic proteins Biotechnol. J. 2010, 5, 113-28
16. Davis, F. F. The origin of pegnology Adv. Drug Delivery Rev. 2002, 54, 457-8
17. Abuchowski, A.; McCoy, J. R.; Palczuk, N. C.; van Es, T.; Davis, F. F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase J. Biol. Chem. 1977, 252, 3582-6
18. Bowen, S.; Tare, N.; Inoue, T.; Yamasaki, M.; Okabe, M.; Horii, I.; Eliason, J. F. Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein Exp. Hematol. 1999, 27, 425-32
19. Manjula, B. N.; Tsai, A.; Upadhya, R.; Perumalsamy, K.; Smith, P. K.; Malavalli, A.; Vandegriff, K.; Winslow, R. M.; Intaglietta, M.; Prabhakaran, M.; Friedman, J. M.; Acharya, A. S. Site-specific PEGylation of hemoglobin at Cys-93(beta): correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain Bioconjugate Chem. 2003, 14, 464-72
20. Lopez-Cruz, J. I.; Viniegra-Gonzalez, G.; Hernandez-Arana, A. Thermostability of native and pegylated Myceliophthora thermophila laccase in aqueous and mixed solvents Bioconjugate Chem. 2006, 17, 1093-8
21. Rosendahl, M. S.; Doherty, D. H.; Smith, D. J.; Carlson, S. J.; Chlipala, E. A.; Cox, G. N. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation Bioconjugate Chem. 2005, 16, 200-7
22. Hu, T.; Prabhakaran, M.; Acharya, S. A.; Manjula, B. N. Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate Biochem. J. 2005, 392, 555-64
23. Manjula, B. N.; Tsai, A. G.; Intaglietta, M.; Tsai, C. H.; Ho, C.; Smith, P. K.; Perumalsamy, K.; Kanika, N. D.; Friedman, J. M.; Acharya, S. A. Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function Protein J. 2005, 24, 133-46
24. Bell, S. J.; Fam, C. M.; Chlipala, E. A.; Carlson, S. J.; Lee, J. I.; Rosendahl, M. S.; Doherty, D. H.; Cox, G. N. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic Bioconjugate Chem. 2008, 19, 299-305
25. Hu, T.; Li, D.; Manjula, B. N.; Acharya, S. A. Autoxidation of the site-specifically PEGylated hemoglobins: role of the PEG chains and the sites of PEGylation in the autoxidation Biochemistry 2008, 47, 10981-90
26. Lui, F. E.; Dong, P.; Kluger, R. Polyethylene glycol conjugation enhances the nitrite reductase activity of native and cross-linked hemoglobin Biochemistry 2008, 47, 10773-80
27. Treetharnmathurot, B.; Ovartlarnporn, C.; Wungsintaweekul, J.; Duncan, R.; Wiwattanapatapee, R. Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin Int. J. Pharm. 2008, 357, 252-9
28. Lui, F. E.; Kluger, R. Enhancing nitrite reductase activity of modified hemoglobin: bis-tetramers and their PEGylated derivatives Biochemistry 2009, 48, 11912-9
29. Rodriguez-Martinez, J. A.; Rivera-Rivera, I.; Sola, R. J.; Griebenow, K. Enzymatic activity and thermal stability of PEG-alpha-chymotrypsin conjugates Biotechnol. Lett. 2009, 31, 883-7
30. Chiu, K.; Agoubi, L. L.; Lee, I.; Limpar, M. T.; Lowe, J. W., Jr.; Goh, S. L. Effects of polymer molecular weight on the size, activity, and stability of PEG-functionalized trypsin Biomacromolecules 2010, 11, 3688-92
31. Palm, T.; Esfandiary, R.; Gandhi, R. The effect of PEGylation on the stability of small therapeutic proteins Pharm. Dev. Technol. 2011, 16, 441-8
32. Li, D.; Hu, T.; Manjula, B. N.; Acharya, S. A. Extension arm facilitated pegylation of alphaalpha-hemoglobin with modifications targeted exclusively to amino groups: functional and structural advantages of free Cys-93(beta) in the PEG-Hb adduct Bioconjugate Chem. 2009, 20, 2062-70
33. Li, D.; Manjula, B. N.; Acharya, A. S. Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation Protein J. 2006, 25, 263-74
34. Otsuka, H.; Nagasaki, Y.; Kataoka, K. PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Delivery Rev. 2003, 55, 403-19
35. Rosenhahn, A.; Schilp, S.; Kreuzer, H. J.; Grunze, M. The role of "inert" surface chemistry in marine biofouling prevention Phys. Chem. Chem. Phys. 2010, 12, 4275-86
36. Karakoti, A. S.; Das, S.; Thevuthasan, S.; Seal, S. PEGylated inorganic nanoparticles Angew. Chem., Int. Ed. 2011, 50, 1980-94
37. Hinterdorfer, P.; Baumgartner, W.; Gruber, H. J.; Schilcher, K.; Schindler, H. Detection and localization of individual antibody-antigen recognition events by atomic force microscopy Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 3477-81
38. Puntheeranurak, T.; Neundlinger, I.; Kinne, R. K.; Hinterdorfer, P. Single-molecule recognition force spectroscopy of transmembrane transporters on living cells Nat. Protoc. 2011, 6, 1443-52
39. Gumpp, H.; Puchner, E. M.; Zimmermann, J. L.; Gerland, U.; Gaub, H. E.; Blank, K. Triggering enzymatic activity with force Nano Lett. 2009, 9, 3290-5
40. Schuler, B.; Lipman, E. A.; Eaton, W. A. Probing the free-energy surface for protein folding with single-molecule fluorescence spectroscopy Nature 2002, 419, 743-7
41. Roy, R.; Hohng, S.; Ha, T. A practical guide to single-molecule FRET Nat. Methods 2008, 5, 507-16
42. Price, J. L.; Powers, E. T.; Kelly, J. W. N-PEGylation of a reverse turn is stabilizing in multiple sequence contexts, unlike N-GlcNAcylation ACS Chem. Biol. 2011, 6, 1188-92
43. Prabhakaran, M.; Manjula, B. N.; Acharya, S. A. Molecular modeling studies of surface decoration of hemoglobin by maleimide PEG Artif. Cells, Blood Substitutes, Immobilization Biotechnol. 2006, 34, 381-93
44. Yang, C.; Lu, D.; Liu, Z. How PEGylation enhances the stability and potency of insulin: a molecular dynamics simulation Biochemistry 2011, 50, 2585-93
45. Grantcharova, V. P.; Baker, D. Folding dynamics of the src SH3 domain Biochemistry 1997, 36, 15685-92
46. Grantcharova, V. P.; Riddle, D. S.; Santiago, J. V.; Baker, D. Important role of hydrogen bonds in the structurally polarized transition state for folding of the src SH3 domain Nat. Struct. Biol. 1998, 5, 714-20
47. Riddle, D. S.; Grantcharova, V. P.; Santiago, J. V.; Alm, E.; Ruczinski, I.; Baker, D. Experiment and theory highlight role of native state topology in SH3 folding Nat. Struct. Biol. 1999, 6, 1016-24
48. Grantcharova, V. P.; Riddle, D. S.; Baker, D. Long-range order in the src SH3 folding transition state Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 7084-9
49. Grantcharova, V. P.; Baker, D. Circularization changes the folding transition state of the src SH3 domain J. Mol. Biol. 2001, 306, 555-63
50. Kinstler, O.; Molineux, G.; Treuheit, M.; Ladd, D.; Gegg, C. Mono-N-terminal poly(ethylene glycol)-protein conjugates Adv. Drug Delivery Rev. 2002, 54, 477-85
51. Fontana, A.; Spolaore, B.; Mero, A.; Veronese, F. M. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase Adv. Drug Delivery Rev. 2008, 60, 13-28
52. Li, J.; Matsumura, Y.; Shinjo, M.; Kojima, M.; Kihara, H. A stable alpha-helix-rich intermediate is formed by a single mutation of the beta-sheet protein, src SH3, at pH 3 J. Mol. Biol. 2007, 372, 747-55
53. Fersht, A. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding; W.H. Freeman: New York, 1999; xxi, 631 pages.
54. Grunwald, E. Thermodynamic properties of nonpolar solutes in water and the structure of hydrophobic hydration shells J. Am. Chem. Soc. 1986, 108, 5726-31
55. Minton, A. P. Molecular crowding: analysis of effects of high concentrations of inert cosolutes on biochemical equilibria and rates in terms of volume exclusion Methods Enzymol. 1998, 295, 127-49
56. Timasheff, S. N. The control of protein stability and association by weak interactions with water: how do solvents affect these processes? Annu. Rev. Biophys. Biomol. Struct. 1993, 22, 67-97
57. Parsegian, V. A.; Rand, R. P.; Rau, D. C. Osmotic stress, crowding, preferential hydration, and binding: A comparison of perspectives Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 3987-92
58. Timasheff, S. N. Protein hydration, thermodynamic binding, and preferential hydration Biochemistry 2002, 41, 13473-82
59. Bhat, R.; Timasheff, S. N. Steric exclusion is the principal source of the preferential hydration of proteins in the presence of polyethylene glycols Protein Sci. 1992, 1, 1133-43